Gsm: 0.507 855 61 15

Gsm: 0.507 855 61 48

Haritada Yerimiz

Eserler

A. Uluslararası hakemli dergilerde yayımlanan makaleler :


A1. Guvenc B., Canataroglu A., Gumurdulu Y., Gumurdulu D., Paydas S., Multiple myeloma with skin involvement, J Eur Acad Dermatol Venereol  2001; 15: 328-329.

A2. Gokcel A., Gumurdulu Y., Karakose H., Karademir BM., Anarat R., Effects of sibutramine in non-dieting obese women, J Endocrinol Invest 2001; 25: 101-105.        

A3. Özer B., Serın E., Gumurdulu Y., Nursal TZ., Noyan T., Kayaselçuk F., Boyacıoglu S., Primary malignant melanoma of the esophagus, Digestive Endoscopy 2002;14:20–21. 

A4. Serin E., Ozer B, Gumurdulu Y., Yildirim T., Barutcu O., Boyacioglu S., A case of Castleman's disease with "downhill" varices in the absence of superior vena cava obstruction, Endoscopy 2002; 34: 160-162.                                                                    

A5.  Gokcel A., Gumurdulu Y., Karakose H., Ertorer ME., Tanaci N., Bascil Tutuncu N., Guvener N., Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity,” Diabetes Obes Metab 2002; 4: 49-55.                                   

A6. Serin E., Kul K., Ozer B., Gumurdulu Y., Boyacioglu S.,  “Hypoglycemia after transjugular intrahepatic portosystemic shunt placement in a cirrhotic patient with diabetes mellitus,” J Clin Gastroenterol 2002; 35: 409-410.                  

A7. Bagis T., Gumurdulu Y., Kayaselcuk F., Yilmaz ES., Killicadag E., Tarim E., “Endoscopy in hyperemesis gravidarum and Helicobacter pylori infection,” Int J Gynaecol Obstet 2002; 79: 105-9.            

A8. Serin E., Gumurdulu Y., Ozer B., Kayaselcuk F., Yilmaz U., Kocak R., Impact of Helicobacter pylori on the development of vitamin B12 deficiency in the absence of gastric atrophy, Helicobacter 2002; 7: 337-41.                                                                          

A9. Serin E, Akkiz H, Doran F, Gumurdulu Y, Gümürdülü D. Obesity and related parameters of non-alcoholic steatohepatitis. Turk J Gastroenterol. 2002;13(2):71-7.     

A10. Kayaselçuk F, Serin E, Gumurdulu Y, Bircan S, Tuncer I. Relationship between gastritis severity, Helicobacter pylori intensity and mast cell density in the antrum and corpus. Turk J Gastroenterol. 2002;13(3):154-8.                                                                       

A11. Gumurdulu Y., Yapar Z., Canataroglu A., Serin E., Gumurdulu D., Kibar M., Colakoglu S.,  Gastric emptying time and the effect of cisapride in cirrhotic patients with autonomic neuropathy, J Clin Gastroenterol 2003; 36: 175-8.                                      

A12. Serin E., Gumurdulu Y., Kayaselcuk F., Ozer B., Yilmaz U., Boyacioglu S., “Halitosis in patients with Helicobacter pylori-positive non-ulcer dyspepsia: an indication for eradication therapy? ”, Eur J Intern Med 2003; 14: 45-48.                                       

A13. Gokcel A., Baltali M., Tarim E., Bagis T., Gumurdulu Y., Karakose H., Yalcin F., Akbaba M., Guvener N.,  “Detection of insulin resistance in Turkish adults: a hospital-based study,” Diabetes Obes Metab 2003;  5: 126-30.                                                  

A14. Gokcel A., Gumurdulu Y., Kayaselcuk F., Serin E., Ozer B., Ozsahin AK., Guvener N., “ Helicobacter pylori has no effect on plasma ghrelin levels,” Eur J Endocrinol 2003;  148: 423-6.                      

A15. Serin E., Yilmaz U., Kunefeci G., Ozer B., Gumurdulu Y., Guclu M., Kayaselcuk F.,Boyacioglu S., Serum positive cagA in patients with non-ulcer dyspepsia and peptic ulcer disease from two centers in different regions of Turkey,” World J Gastroenterol 2003; 9: 833-5.                                                                                                               

A16. Canataroglu A., Gumurdulu Y., Gumurdulu D., Balal M., Tuncer I., Sagliker Y.,  “Coexistence of cystic intra-abdominal lymphangiomas and diffuse venous haemangiomas in adult life,”Neth J Med 2003; 61: 95-7.                                                           

A17. Serin E., Ozer B., Gumurdulu Y., Kayaselcuk F., Kul K., Boyacioglu S.,  “Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver,” J Gastroenterol 2003;  38: 471-6.                                                                                     

A18. Gumurdulu Y., Serin E., Ozer B., Aydin M., Yapar AF., Kayaselcuk F., Yilmaz U., Boyacioglu S., “The impact of B12 treatment on gastric emptying time in patients with Helicobacter pylori infection,” J Clin Gastroenterol 2003; 37: 230-3.                             

A19. Ozer B, Serin E, Yilmaz U, Gumurdulu Y, Saygili OB, Kayaselçuk F, Boyacioğlu S. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey. Turk J Gastroenterol. 2003; 14(2):85-90.                  

A20. Ozer B, Serin E, Gumurdulu, Gür G, Yilmaz U, Boyacioğlu S. Endoscopic extraction of living fasciola hepatica: case report and literature review. Turk J Gastroenterol. 2003;14(1):74-7.                                                                                     

A21. Gumurdulu Y, Serin E, Ozer B, Kayaselçuk F, Kul K, Pata C, Güçlü M, Gür G, Boyacioğlu S. Predictors of vitamin B12 deficiency: age and Helicobacter pylori load of antral mucosa. Turk J Gastroenterol. 2003;14(1):44-9.                                                    

A22. Gumurdulu Y., Serin E., Ozer B., Gokcel A., Boyacioglu S., Age as a predictor of hyperphosphatemia after oral phosphosoda administration for colon preparation,  J Gastroenterol Hepatol 2004; 19: 68-72.                    

A23. Gumurdulu Y., Serin E., Ozer B., Kayaselçuk F., Özşahin K., Coşar MA., Gursoy M., Gur G., Yılmaz U., Boyacıoglu S., Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple  therapy in  Turkey, World J Gastroenterol 2004; 10: 668-71.                          

A24. Kayaselcuk F, Serin E, Gumurdulu Y, Ozer B, Tuncer I, Boyacioglu S., Subepithelial basement membrane thickness in patients with normal colonic mucosal appearance in colonoscopy: results from southern Turkey, World J Gastroenterol 2004; 10: 1056-8.                                                                                                                     

A25. Guclu M, Serin E, Ulucan S, Kul K, Ozer B, Gumurdulu Y, Pata C, Cosar A, Gur G, Boyacioglu S. Agenesis of the dorsal pancreas in a patient with recurrent acute pancreatitis: case report and review,  Gastrointes Endosc 2004;  60: 472-5.                

A26. Ozer B, Serin E, Gumurdulu Y, Kayaselcuk F, Anarat R, Gur G, Kul K, Guclu M, Boyacioglu S. Helicobacter pylori eradication lowers serum homocysteine level in patients without gastric atrophy,  World J Gastroenterol 2005; 11: 2764-7.                                         

A27. Serin E, Pourbagher MA, Gümürdülü Y, Tamer L, Ozer B, Yilmaz U. The effect of decrease in serum nitric oxide concentration on portal hemodynamics after Helicobacter pylori treatment: an open-label pilot study. Turk J Gastroenterol 2008; 19(3):158-62. 

A28. Gümürdülü Y, Karakoç E, Kara B, Taşdoğan BE, Parsak CK, Sakman G. The efficiency of sucralfate in corrosive esophagitis: a randomized, prospective study. Turk J Gastroenterol. 2010; 21(1):7-11.

A29. Kara B, Akkiz H, Doran F, Bayram S, Erken E, Gumurdullu Y, Sandikci M. The significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis? Clin Exp Med. 2010;10(2):107-12.

A30. Doğan ÜB, Gümürdülü Y, Gölge N, Kara B,. Relationship of CA 19-9 with choledocholithiasis and cholangitis. Turk J Gastroenterol. 2011;22(2):171-7.

A31. Olmez S, Gümürdülü Y, Tas A, Karakoc E, Kara B, Kidik A. Prognostic markers in cirrhotic patients requiring intensive care: a comparative prospective study. Annals of Hepatology 2012; 11(4): 513-518.                                                                                     

A32. Doğan ÜB, Kara B, Gümürdülü Y, Soylu A, Akin MS. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B. Turk J Gastroenterol. 2012; 23(3):247-52.                                                   

A33. Dogan UB, Gumurdulu Y, Akin MS, Yalaki S. Five Percent Weight Lost in the First Month of Intragastric Balloon TreatmentMay Be a Predictor for Long-Term Weight  Maintenance. Obes Surg. 2013 Feb 13. [Epub ahead of print]                                          

A34. Gumurdulu Y, Dogan UB, Akin MS, Tasdogan BE, Yalaki S Long-term Effectiveness of BioEnterics intragastric balloon in Obese Patients. Turk J Gastroenterol (yayına kabul edildi. doi:10.4318/ tjg.0696 ).                                                                                      

B. Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında (Proceedings) basılan bildiriler :


B1. Gumurdulu Y., Yapar Z., Kibar M., Colakoglu S.O., Reyhan M.“The value of cisapride on the prolonged gastric emptying time in cirrhotic patients”, Eur J Nucl Med, 26-9, 1097, 1999.  

B2. Gumurdulu Y., Yapar Z., Kibar M., Colakoglu S.O., Reyhan M. “Determination of  gastric emptying in cirrhotic patients using radiolabelled solid meals”, Eur J Nucl Med, 27-8, 1076, 2000. 

B3. Gokcel A., Gumurdulu Y., Karakose H., Karademir BM., Anarat R., Effects of Sibutramine on Leptin Levels in Non-Dieting Obese Women. 10th European Congress,  Antwerp-Belgium , 24-27 May 2000.

B4. Gokcel A., Gumurdulu Y., Karakose H., Ertorer EM., Tanaci N., Tutuncu NB., Guvener N., Evaluation of the Safety and Efficacy of Sibutramine, Orlistat, and Metformin in the Treatment of Obesity. 11th European Congress on Obesity, Vienna; 30 May – 2 June, 2001. 

B5. Serin E., Ozer B., Gumurdulu Y., Boyacioglu S., “The role of serum leptin level in progression from steatosis to steatohepatitis”. 37 Annual Meeting of EASL, Madrid, Spain, Journal of Hepatology 36 Suppl 1, 151, 2002.

B6.  Ozer B., Serin E., Gumurdulu Y., Saygılı OB., Kayaselcuk F., Boyacıoglu S., “Hepatocelluler carcinoma in Southern Anatolia (single center): Epidemiological and clinicopathological characteristics and risk factors”. 12th World Congress of The International Association of Surgeons and Gastroenterologists., İstanbul, Turkey 2002.

B7. Gokcel A., Baltali M., Tarim E., Bagis T., Gumurdulu Y., Karakose H., Guvener N., Detection of Insulin Resistance in Turkish Adults: a Hospital Based Study. 6th European Congress of Endocrinology, Lyon, France, 26-30 April 2003.                                      

B8. Gokcel A., Gumurdulu Y., Kayaselcuk F., Serin E., Ozer B., Guvener N., Ozsahin K. Helicobacter Pylori Has No Effect on Plasma Ghrelin Levels. 6th European Congress of Endocrinology , Lyon-France 26-30 April 2003. 

B9. Serin E., Gumurdulu Y., Ozer B., Kayaselcuk F., Yilmaz U., Boyacioglu S., “The demographic, hematologic, endoscopic, and histologic parameters predicting or influencing the presence of viatmin B12 deficiency”, Digestive Disease Week, Orlando, Florida, USA, May 17-22, 2003.   

B10. Gumurdulu Y., Serin E., Ozer B., Aydin M., Kayaselcuk F., Yilmaz U., Boyacioglu S., “The impact of B12 treatment on gastric emptying time in patients with helicobacter pylori infection”, Digestive Disease Week, Orlando, Florida, USA, May 17-22, 2003.

B11.  Gumurdulu Y , Sunbul AT , Ozdil B , Kara B , Parsak CK , Sakman G , Colakoglu S , Akkiz H. The comparision of intense sucralfate therapy with standard therapy in patients having recent stage corosive esophagitis. Digestive Disease Week, Washington DC , USA, May 19-24, 2007.    

B12. Gumurdulu Y , Kidik A , Kara B , Ozdil B, Yapar Z , Colakoglu S, Hikmet A Is it the diapghramatic defects that only responsible for hepatic hydrothorax pathogenesis? .   Digestive Disease Week, Washington DC , USA, May 19-24, 2007.                             

B13. Doğan ÜB,  Gumurdulu Y, Golge N. CA 19-9 levels in patients with choledocholithiasis. UEGW London 2009. Gut (2009) Vol:58 Supp. II.                       

B14. Olmez S, Gumurdulu Y, Tasdogan BE. The risk factor for mortality cirrotic patients hospitalized in intensive care unit. Digestive Disease Week, Chicago, 2009.             

B15. Gumurdulu Y, Taşdogan BE, Doğan ÜB. Coll. The frequency of hepatitis B infection in patient with ulcerative colitis: Do they have an increased risk for viral hepatitis.  APASL Pekin march 2010. Hepatology international (2010) 5:3-558 p:135.               

B16. Gumurdulu Y, Doğan UB, Kara B, Ark. The correlation of HBsAg and HBV-DNA in Chronic hepatitis B treatment. APASL Bankong march 2011. Hepatology international (2011) 5:3-558 p:135.

B17. Doğan ÜB, Kara B, Gumurdulu Y, Soylu A, Akin MS. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B. APASL Bankong march 2011. Hepatology international (2011) 5:3-558 p:135.

B18. Gumurdulu Y , Doğan UB, Taşdogan BE.  Do patients with chronic hepatitis B infection are awere of delta hepatitis. APASL Bankong march 2011. Hepatology international (2011) 5:3-558 p:203.

B19. Gumurdulu Y. ,Doğan UB. Akın S. Long-term effectiveness of bioenterics intragastric balloon in obese patients. Asian Pasific Digestive Week, Bangkong, 2012.

D. Ulusal hakemli dergilerde yayımlanan makaleler :


D1. Serin E., Gümürdülü Y., Çolakoğlu S., Hafta A., Gümürdülü D., “Kolorektal kanserlerin son senelerdeki lokalizasyonu”, Çukurova Üniversitesi Tıp Fakültesi Dergisi, 1997;  22: 122-126. 

D2. Doran F., Gümürdülü D., Ergin M., Gümürdülü Y., Hafta A., “Ülseratif kolit olgularında lamina propriada eozinofil lökositler ve mast hücreleri”, Çukurova Üniversitesi Sağlık Bilimleri Dergisi, 1998; 13: 9-13.

D3. Çolakoğlu SÖ., Gümürdülü Y., Gümürdülü D., Alabaz Ö., Zeren H., “Mezenter kökünden orijinini alan dev bir ince barsak leiomyoması” (Olgu sunumu ve literatür taraması), Türkiye Klinikleri Gastroenterohepatoloji Dergisi, 1999; 10: 133-136.       

D4. Doran F., Ergin M., Uğuz A., Gümürdülü D., Gümürdülü Y., “İto hücrelerinin kronik C hepatitine bağlı fibrozisde rolü”, Türkiye Klinikleri Gastroentero hepatoloji Dergisi, 2000; 11: 57-60.

D5. Canataroğlu A., Gümürdülü Y., Erdem A., Çolakoğlu S., “Prevalence of fibromyalgia in patients with irritable bowel syndrome”. The Turkish Journal of Gastroenterology, 2001; 12: 141-144.

D6. Özer B. , Serın E. , Gümürdülü Y, “Gastrik varislerin tedavisinde endoskopik cyanoacrylate injeksiyonunun etkinlik ve güvenilirliği”, Güncel Gastroenteroloji, 2001; 5: 179-184.

D7. Gökcel A., Baltalı M., Gümürdülü Y., Özşahin AK., Güvener N., Bascil Tütüncü N., “Yüksek dansiteli lipoprotein dışı kolesterolun klinik kullanımı”, Türkiye Klinikleri Kardiyoloji Dergisi, 2002; 15: 165-169.

D8. Serin E., Özer B., Gümürdülü Y., Boyacıoğlu S., “Biliary Sludge associated with chronic hypocalemia in bartter’s syndrome ”, Annals of medical science, 2002; 11: 52-54.

D9. Gümürdülü Y., Serin E. , Özer B., “Hepatik Hidrotorax”, Güncel Gastro-enteroloji, 2002; 6: 229-233.

D10. Gümürdülü Y., Serin E., Özer B., Gökçel A., Yılmaz U., Boyacıoğlu S., “Oral fosfosoda kullanımı sonrası hiperfosfatemi gelişen iki vakalık olgu sunumu”, Diyaliz, Transplantasyon ve Yanık, 2002; 13: 42-45.

D11. Serin E., Gümürdülü Y., Özer B., Kayaselçuk F., Tuncer İ., “Intestinal T-Cell lymphoma Unlike Lymphoma secondary to celiac disease: A case of a middle-aged male”, Turkısh J Hematology and Oncology, 2003; 13: 38-43.

D12. Serin E., Kayaselçuk F., Köksal F., Özer B., Gümürdülü Y., Boyacıoğlu S., “Helicobacter Pylori CagA status predicts severity of bulbar pathology but not severity of gastritis in Turkish patients ”, Annals of Medical Sciences, 2003; 12: 72-78.                   

D13. Eğilmez T., Gümürdülü Y, Güvel S., Kılınç F., Yaycığlu Ö., Özkardeş H. “Kolonoskopi ve rektoskopinin erken dönemde serum total, serbest ve serbest/total prostat spesifk antijen değerleri üzerine etkileri,” Türk Üroloji Dergisi, 2004; 30: 86-90.

D14. Kayaselçuk F, Gümürdülü Y, Özşahin K, Serin E, Tuncer İ. “Relationship among severity of inflamation, helicobacter pylori infection, and mast cell density in the antrum and corpus: An immunohistochemical study by mast cell tryptase,” Mersin Üniversitesi Tıp Fakültesi Dergisi 2004; 2: 132-137. 

D15. Kayaselçuk F, Gümürdülü Y, Bolat F, Özer B, Bal N, Tuncer İ. Granülamatoz gastritisli altı olgunun klinikopatolojik analizi. Akademik Gastroenteroloji Dergisi, 2005; 4 (2): 121-124.

D16. Gümürdülü Y, Taşdoğan BE. Peptik Duodenal ve Gastrik Ülserler Aynı mı Değil mi? Turkiye Klinikleri J Gastroenterohepatol-Special Topics 2009;2(3):14-8.            

D17. Taşdoğan BE, Gümürdülü Y. Halitozis ve Helikobakter pilori. Güncel Gastroenteroloji 2011; 15(3):158-160.

D18. Taşdoğan BE, Gümürdülü Y Özofagus buji dilatasyonu sırasında görülen bir komplikasyon, kılavuz telin mide içerisinde düğümlenmesi. Endoskopi Dergisi  2011;19(2): 78-79.

D19. Taşdoğan BE, Gümürdülü Y Sirotik Hastalarda Endoskopide Sedasyon. Güncel Gastroenteroloji. 2011.15(1).52-57. Güncel Gastroenteroloji. 2011;15(3).158-160.  

D20. Taşdoğan BE, Gümürdülü Y. Gıda empaksiyonları ve yutulmuş yabancı cisimlerin yönetimi (ASGE kılavuzu - 2011). Skop Gastrointestinal Endoskopi Dünyası. 2011; 6: 20-22.

D21. Gümürdülü Y, Taşdoğan BE. Özel Gruplarda Gastrointestinal Sistem Endoskopisi. Turkiye Klinikleri J Gastroenterohep-Special Topics 2012; 5(1): 27-32.